Faes Farma S.A.

Address: Autonomia Etorbidea 10

Sponsor Overview

assignment

Specializations

Gastroenterology and Inflammatory Bowel Disease

Faes Farma S.A. supports clinical research in ulcerative colitis and chronic idiopathic inflammatory bowel disease, with attention to symptoms, intestinal inflammation, and remission outcomes in patients with active disease.

Ulcerative colitis
Clinical remission
Mesalazine

The sponsor’s gastrointestinal portfolio also includes studies in oral mesalazine formulations and their use in controlling disease activity.

Allergy and Respiratory Immunology

Another major area of interest is allergic rhinoconjunctivitis and broader allergy care, including research on symptom relief, ocular and nasal manifestations, and treatment response in both adults and children.

Allergic rhinoconjunctivitis
Antihistamine therapy
Pediatric allergy

Trials in this field examine oral allergy medicines such as bilastine, ebastine, and desloratadine.

Clinical Pharmacology in Healthy Volunteers

Faes Farma S.A. also funds pharmacokinetic research in healthy volunteers, focusing on how oral medicines are absorbed and handled by the body under fasting and fed conditions.

Pharmacokinetics
Bioequivalence
Healthy volunteers

These studies include comparisons of oral formulations for medicines such as dexketoprofen, mesalazine, and alendronic acid.

Bone and Musculoskeletal Therapeutics

The sponsor’s research landscape extends to alendronic acid formulations, reflecting interest in therapies used in bone health and related musculoskeletal treatment settings.

Alendronic acid
Oral formulations
Bioavailability

Work in this area is centered on oral delivery and comparative performance of formulations in healthy subjects.

Sponsored Trials

Trial Name	Country	Status
A Comparative Bioavailability Study of Two Oral Formulations of Dexketoprofen in Healthy Volunteers Under Fasting Conditions	Czechia	Not Recruiting
Comparative Pharmacokinetics of Two Alendronic Acid Formulations in Healthy Volunteers: A Randomized, Open-Label, Single-Dose, Crossover Study	Czechia	Not Recruiting
Comparative Study of Bilastine, Ebastine, and Desloratadine on Histamine-Induced Wheal and Flare Suppression in Healthy Volunteers	Spain	Not Recruiting
Evaluation of Food Effect on Pharmacokinetics of Mesalazine Oral Formulation in Healthy Volunteers with Ulcerative Colitis	Spain	Not Recruiting
International multicentre, open-label, phase IV clinical trial to evaluate the efficacy, safety and effect on quality of life of bilastine in children with allergic rhinoconjunctivitis	Italy Poland Spain	Recruiting
Pharmacokinetic Comparison of Two Oral Mesalazine Formulations in Healthy Volunteers Under Fed Conditions for Chronic Idiopathic Inflammatory Bowel Disease	Spain	Not Recruiting
Pharmacokinetic Evaluation of Alendronic Acid Oral Formulations in Healthy Volunteers Under Fasted Conditions: A Randomized, Open-Label, Crossover Study	Czechia	Not Recruiting